Appeals Court Upholds Invalidation of ABL-held Patents on Computerized Treatment Selection Methods | GenomeWeb

SmartGene said this week that the United States Court of Appeals for the Federal Circuit has upheld a favorable ruling from the US District Court for the District of Columbia that invalidates two patents held by Advanced Biological Laboratories that are at the heart of a nearly seven-year lawsuit between the companies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.